2026 Sunil R. Lakhani: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	112	5051	4737	138	133	550	70230

Sunil R. Lakhani publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sunil R. Lakhani sits on this spectrum.

101 publications 1,796+

This scientist: 550 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sunil R. Lakhani D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sunil R. Lakhani sits on this spectrum.

70 D-Index 217+

This scientist: 112 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sunil R. Lakhani is affiliated with the University of Queensland in Australia and has made significant contributions in the fields of medicine, biochemistry, genetics, and molecular biology. Their research primarily focuses on cancer-related studies, particularly in oncology, molecular biology, and cancer research as well as pulmonary and respiratory medicine and pathology and forensic medicine.

The main topics of their research include:

Cancer Genomics and Diagnostics
Breast Cancer Treatment Studies
Breast Lesions and Carcinomas
Brain Metastases and Treatment
Cancer Immunotherapy and Biomarkers
BRCA gene mutations in cancer
Cancer Cells and Metastasis

Frequent publication venues for Sunil R. Lakhani's work comprise:

Histopathology
bioRxiv (Cold Spring Harbor Laboratory)
Cancers
Journal of Clinical Oncology
Annals of Oncology

The scientist often collaborates with several co-authors, including:

Amy E. McCart Reed
Peter T. Simpson
Jodi M. Saunus
Kaltin Ferguson
Jamie R. Kutasovic

Recent notable publications by Sunil R. Lakhani include:

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer, 2021, New England Journal of Medicine
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update, 2020, Journal of Clinical Oncology
The 2019 World Health Organization classification of tumours of the breast, 2020, Histopathology
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer, 2022, Annals of Oncology
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update, 2020, Archives of Pathology & Laboratory Medicine

Best Publications

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio

10789
Citations
Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

3090
Citations
WHO classification of tumours of the breast

Sunil R. Lakhani;Ian O. Ellis;Stuart J. Schnitt;Puay Hoon Tan

2558
Citations
Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna

2186
Citations
The landscape of cancer genes and mutational processes in breast cancer

Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo

1903
Citations
Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

1400
Citations
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

M O Leach;C R M Boggis;A K Dixon;D F Easton

1296
Citations
The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2

Sunil R. Lakhani;Marc J. van de Vijver;Jocelyne Jacquemier;Thomas J. Anderson

1189
Citations
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

Lin Zhang;Siyuan Zhang;Siyuan Zhang;Jun Yao;Frank J. Lowery

1139
Citations
Breast cancer prognostic classification in the molecular era: the role of histological grade

Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

1121
Citations
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Andrew N.J. Tutt;Judy E. Garber;Bella Kaufman;Giuseppe Viale

1096
Citations
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

Kimberly H. Allison;M. Elizabeth H. Hammond;Mitchell Dowsett;Shannon E. McKernin

981
Citations
Patterns of somatic structural variation in human cancer genomes

Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

942
Citations
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

Helen Davies;Dominik D. Glodzik;Sandro S. Morganella;Lucy R. Yates

941
Citations
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

897
Citations
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

870
Citations
Identification of the familial cylindromatosis tumour-suppressor gene.

Graham R. Bignell;William Warren;Sheila Seal;Meiko Takahashi

833
Citations
Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations

Sunil R. Lakhani;Jocelyne Jacquemier;John P Sloane;Barry A. Gusterson

816
Citations
Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

Sunil R. Lakhani;Jorge S. Reis-Filho;Laura Fulford;Frederique Penault-Llorca

810
Citations
Molecular evolution of breast cancer

Peter T Simpson;Jorge S Reis-Filho;Jorge S Reis-Filho;Jorge S Reis-Filho;Theodora Gale;Sunil R Lakhani

730
Citations

Frequent Co-Authors

Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center

Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute

Stephen B. Fox Peter MacCallum Cancer Centre

Michael R. Stratton Wellcome Sanger Institute

Kum Kum Khanna Mater Research

Nicola Waddell QIMR Berghofer Medical Research Institute

Andrea L. Richardson Johns Hopkins University

Chris Jones Institute of Cancer Research

Serena Nik-Zainal University of Cambridge

Anne Lise Børresen-Dale Oslo University Hospital

External Links

Personal website of Sunil R. Lakhani

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring related healthcare degrees online can open a variety of career pathways beyond traditional medical school. For those aiming to advance nursing practice with flexibility and affordability, check out cheap dnp online programs. These programs are ideal for nurses who want to move into leadership or specialized clinical roles.

If you’re interested in medication management and pharmaceutical care, consider researching pharmacy school online. Online pharmacy doctorates can help students balance work, family, and education, while preparing for pharmacist licensure exams.

For those drawn to healthcare IT and data management, earning an him bachelor's degree online is a smart choice. This pathway prepares graduates to handle sensitive medical data and support quality patient care in a digital age.

Another fast-growing field is medical administration. Prospective students frequently ask how much is medical billing and coding school. Online courses in this area are often affordable and offer a quick route into healthcare without extensive clinical training.